UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Reconstitution of the immune system after hematopoietic stem cell transplantation in humans

Seminars in immunopathology, 2008-12, Vol.30 (4), p.425-437

2008

Volltextzugriff (PDF)

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes

Haematologica (Roma), 2023-02, Vol.108 (2), p.532

2023

Volltextzugriff (PDF)

Immune reconstitution following hematopoietic stem-cell transplantation

Best practice & research. Clinical haematology, 2007-06, Vol.20 (2), p.329-348

2007

Volltextzugriff (PDF)

Curability and transferability of atopy with allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2020-07, Vol.55 (7), p.1282-1289

2020

Volltextzugriff (PDF)

Outcomes of patients with relapsed or refractory acute myeloid leukemia: a population-based real-world study

American journal of blood research, 2020-01, Vol.10 (4), p.124-133

2020

Volltextzugriff (PDF)

Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation?

Blood, 2009-01, Vol.113 (2), p.279-290

2009

Volltextzugriff (PDF)

Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti‐thymocyte globulin myeloablative conditioning

Transplant infectious disease, 2017-06, Vol.19 (3), p.n/a

2017

Volltextzugriff (PDF)

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Journal of antimicrobial chemotherapy, 2017-12, Vol.72 (12), p.3406-3413

2017

Volltextzugriff (PDF)

Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study

British journal of haematology, 2016-07, Vol.174 (1), p.88-101

2016

Volltextzugriff (PDF)

A retrospective, real-world population-based analysis of treatment patterns and outcomes in adult patients with relapsed/refractory acute myeloid leukemia in Alberta, Canada

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e18505-e18505

2019

Volltextzugriff (PDF)

Differential Gene Expression Using RNA Sequencing Between Elderly Acute Myeloid Leukemia (AML) Patients with Long Versus Short-Term Survival

Blood, 2016-12, Vol.128 (22), p.1683-1683

2016

Volltextzugriff (PDF)

Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study

British journal of haematology, 2021-07, Vol.194 (2), p.319-324

2021

Volltextzugriff (PDF)

Revised 15-item MDS-specific frailty scale maintains prognostic potential

Leukemia, 2020-12, Vol.34 (12), p.3434-3438

2020

Volltextzugriff (PDF)

Fatigue, However Measured, Continues to Refine Prognosis in Higher Risk MDS: An MDS-CAN Study

Blood, 2020-11, Vol.136 (Supplement 1), p.41-43

2020

Volltextzugriff (PDF)

High Transfusion Dependence and Serum Ferritin but Not Transferrin Saturation Predict Inferior Clinical Outcomes in Patients with MDS

Blood, 2020-11, Vol.136 (Supplement 1), p.47-48

2020

Volltextzugriff (PDF)

A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry

Leukemia & lymphoma, 2022-11, Vol.63 (13), p.3165-3174

2022

Volltextzugriff (PDF)

Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS

Leukemia research, 2018-11, Vol.74, p.21-41

2018

Volltextzugriff (PDF)

Prognostic Performance of Frailty Measures in MDS Patients Treated with Hypomethylating Agents

Blood, 2019-11, Vol.134 (Supplement_1), p.4245-4245

2019

Volltextzugriff (PDF)

Intermittent Transfusion Independence Is Associated with Improved Overall Survival in Patients with Transfusion Dependent MDS

Blood, 2019-11, Vol.134 (Supplement_1), p.5416-5416

2019

Volltextzugriff (PDF)

First Reported Case of Lymphomatoid Granulomatosis Associated with Azathioprine Therapy in Crohnʼs Disease: 1269

The American journal of gastroenterology, 2012-10, Vol.107, p.S504-S505

2012

Volltextzugriff (PDF)

Health Related Quality of Life Remains Stable over Time in Myelodysplastic Syndrome: An MDS-CAN Prospective Study

Blood, 2018-11, Vol.132 (Supplement 1), p.4850-4850

2018

Volltextzugriff (PDF)

Predictive Factors of Overall Survival and the Completion of Four Cycles of Azacitidine: An MDS-CAN Study

Blood, 2017-12, Vol.130, p.4253-4253

2017

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(92)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(46)
Humans
(36)
Female
(22)
Hematology
(18)
Male
(16)
Adult
(13)
Middle Aged
(13)
Aged
(12)
Immunology
(10)
Hematology, Oncology And Palliative Medicine
(9)
Transplantation
(9)
Animals
(8)
Nursing
(8)
Breast Milk
(7)
Busulfan - Administration & Dosage
(7)
Myelodysplastic Syndromes
(7)
Vidarabine - Analogs & Derivatives
(7)
Adolescent
(6)
Bacteria
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reconstitution of the immune system after hematopoietic stem cell transplantation in humans

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes

Immune reconstitution following hematopoietic stem-cell transplantation

Curability and transferability of atopy with allogeneic hematopoietic cell transplantation

Outcomes of patients with relapsed or refractory acute myeloid leukemia: a population-based real-world study

Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation?

Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti‐thymocyte globulin myeloablative conditioning

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study

Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an MDS‐CAN analysis

A retrospective, real-world population-based analysis of treatment patterns and outcomes in adult patients with relapsed/refractory acute myeloid leukemia in Alberta, Canada

Differential Gene Expression Using RNA Sequencing Between Elderly Acute Myeloid Leukemia (AML) Patients with Long Versus Short-Term Survival

Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study

Safety and Efficacy of Cusatuzumab in Combination with Venetoclax and Azacitidine (CVA) in Patients with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Eligible for Intensive Chemotherapy; An Open-Label, Multicenter, Phase 1b Study

Revised 15-item MDS-specific frailty scale maintains prognostic potential

Fatigue, However Measured, Continues to Refine Prognosis in Higher Risk MDS: An MDS-CAN Study

High Transfusion Dependence and Serum Ferritin but Not Transferrin Saturation Predict Inferior Clinical Outcomes in Patients with MDS

A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry

Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS

Prognostic Performance of Frailty Measures in MDS Patients Treated with Hypomethylating Agents

Intermittent Transfusion Independence Is Associated with Improved Overall Survival in Patients with Transfusion Dependent MDS

First Reported Case of Lymphomatoid Granulomatosis Associated with Azathioprine Therapy in Crohnʼs Disease: 1269

Health Related Quality of Life Remains Stable over Time in Myelodysplastic Syndrome: An MDS-CAN Prospective Study

Prognostic Impact of Insertion Site in Acute Myeloid Leukemia (AML) with FLT3 Internal Tandem Duplication: Results from the Ratify Study (Alliance 10603)

Predictive Factors of Overall Survival and the Completion of Four Cycles of Azacitidine: An MDS-CAN Study

Suchergebnisse filtern